Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

S. Wang , X. Gu , D. Xu , B. Liu , K. Qin , and X. Yuan , "Comprehensive Analysis of m6A Modification Patterns and m6A-Related lncRNAs as Potential Biomarkers in Lung Adenocarcinoma," Environmental Toxicology 39, no. 4 (2024): 2285-2303, https://doi.org/10.1002/tox.24110. The above article, published online on 26 December 2023, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Christyn Bailey; and Wiley Periodicals LLC. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. Therefore, the article must be retracted. Sheng Wang disagrees with this decision. Xuyu Gu was unaware that they were included as an author on this submission and was not involved with its creation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/tox.24512DOI Listing

Publication Analysis

Top Keywords

analysis m6a
8
m6a modification
8
modification patterns
8
patterns m6a-related
8
m6a-related lncrnas
8
lncrnas potential
8
potential biomarkers
8
biomarkers lung
8
retraction comprehensive
4
comprehensive analysis
4

Similar Publications

Bladder cancer (BlCa) exhibits a highly heterogeneous molecular landscape and treatment response, underlining the pressing need for personalized prognosis. N6-methyladenosine (m6A) constitutes the most abundant RNA modification, modulates RNA biology/metabolism, and maintains cellular homeostasis, with its dysregulation involved in cancer initiation and progression. Herein, we evaluated the clinical value of METTL3 m6A methyltransferase, the main catalytic component of m6A methylation machinery, in improving BlCa patients' risk stratification and prognosis.

View Article and Find Full Text PDF

Epilepsy is a common chronic nervous system disease that threatens human health. However, the role of FOXC1 and its relations with pyroptosis have not been fully studied in epilepsy. Sprague-Dawley rats were obtained for constructing temporal lobe epilepsy (TLE) models.

View Article and Find Full Text PDF

RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine, and pseudouridine, serve as pivotal regulators of gene expression with significant implications for human health and disease. These dynamic modifications influence RNA stability, splicing, translation, and interactions, thereby orchestrating critical biological processes such as embryonic development, immune response, and cellular homeostasis. Dysregulation of RNA modifications is closely associated with a variety of pathologies.

View Article and Find Full Text PDF

Epitranscriptomic modifications regulate gene expression and have been implicated in cancer, including breast cancer. Using the SCAN-B cohort, we analyzed 49 messenger RNA modification regulators (mRMPs) across breast cancer subtypes. In the basal subtype, we found significant overexpression of mA readers (IGF2BP1-3), mC regulators (NSUN5, ALYREF, YBX1, YBX2), pseudouridine [PUS1, MARS (or MetRS), RPUSD2], and RNA editing enzymes [APOBEC3A (A3A), A3G, ADAR1], all linked to poor survival.

View Article and Find Full Text PDF

Immunogenic Cell Death Genes Related Prognostic Biomarker in Hepatocellular Carcinoma.

Oncol Res

September 2025

Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.

Objectives: Hepatocellular carcinoma (HCC) is among the most frequently occurring malignant tumors of the digestive tract and is associated with an increased mortality rate worldwide. This study aimed to develop and validate a prognostic model based on immunogenic cell death (ICD)-related genes to predict patient survival and guide individualized treatment strategies for HCC.

Methods: ICD-related genes were identified from the GeneCards database using a relevance score threshold of >10.

View Article and Find Full Text PDF